Abstract
The objective of this study was to compare the blood-brain barrier (BBB) transport and brain distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated using retrodialysis by drug, were placed into the frontal cortex and right jugular vein of eight guinea pigs. Racemic CZE (2.7 mg/kg) was administered as a 60-min i.v. infusion. Unbound and total concentrations of the enantiomers were measured in blood and brain with liquid chromatography-tandem mass spectrometry. The brain distribution of the CZE enantiomers were compared using the parameters Kp,Kp,u,Kp,uu, and Vu,br. Kp compares total brain concentration to total plasma concentration, Kp,u compensates for binding in plasma, whereas Kp,uu also compensates for binding within the brain tissue and directly quantifies the transport across the BBB. Vu,br describes binding within the brain. The stereoselective brain distribution indicated by the Kp of 0.22 and 0.04 for S- and R-CZE, respectively, was caused by different binding to plasma proteins. The transport of the CZE enantiomers across the BBB was not stereoselective, since the Kp,uu was 0.17 and 0.14 (N.S.) for S- and R-CZE, respectively. The Kp,uu values show that the enantiomers are effluxed to a large extent across the BBB. The Vu,br of approximately 2.5 ml/g brain was also similar for both the enantiomers, and the value indicates high binding to brain tissue. Thus, when determining stereoselectivity in brain distribution, it is important to study all factors governing this distribution, binding in blood and brain, and the BBB equilibrium.
Footnotes
-
This work was supported by UCB S.A., Braine-l'Alleud, Belgium. These data were presented at Pharmaceutical Sciences World Congress 2004, Kyoto, Japan, May 30–June 4, 2004.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.105.007211.
-
ABBREVIATIONS: BBB, blood-brain barrier; CZE, cetirizine; R-CZE, levocetirizine; S-CZE, dextrocetirizine; ISF, interstitial fluid; IS, internal standard; BSA, bovine serum albumin; AUC, area under the curve; CL, clearance.
- Received September 5, 2005.
- Accepted November 18, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|